Write Quicker PBPK Reports with the Simcyp Report Assistant Blog Post
Harry Moore April 11, 2025 Writing a report for PBPK models can be an onerous process, especially when the report requires the compilation of data from different sources. The Simcyp...
Delivering DSUR Excellence for Multinational Biopharma Blog Post
A global leader in immuno-oncology approached us for support with over 50 simple to complex Development Safety Update Reports (DSURs) with tight timelines. Below, we explore how we worked with...
Model-Based Meta-Analysis (MBMA) for Relative Treatment Effects and Absolute Outcomes: A Focus on Concepts and Applications Blog Post
May 27, 2025 – 11am ET
Revolutionizing Medical Writing: AI Accelerates Drug Development Efficiency [Chinese webinar] Blog Post
Overview This webinar is available only in Chinese. Artificial intelligence (AI) is revolutionizing drug development at an unprecedented rate. Certara.AI leverage AI to streamline key processes, including drug discovery, clinical...
How Certara MIDD Experts Overcame Client Regulatory Challenges Blog Post
Certara’s Model-Informed Drug Development (MIDD) approach leverages an integrated, quantitative systems methodology to accelerate regulatory approval and commercial success while minimizing time and costs. With a global team of 700+...
Standardizing Real World Data in Rare Disease: ATHN’s Journey Blog Post
The American Thrombosis and Hemostasis Network (ATHN), a not-for-profit organization, has been improving care and advancing research for individuals with rare blood disorders since its founding in 2006. ATHN sponsors...
